Real‐world genomic landscape of colon and rectal cancer
MAPK signaling activation is an important driver event in colorectal cancer (CRC) tumorigenesis that informs therapy selection, but detection by liquid biopsy can be challenging. We analyze real‐world comprehensive genomic profiling (CGP) data to explore the landscape of alterations in BRAF or RAS i...
Saved in:
| Main Authors: | Markus Schulze, XiaoZhe Wang, Jawad Hamad, Julia C. F. Quintanilha, Lincoln W. Pasquina, Julia F. Hopkins, Juergen Scheuenpflug, Zheng Feng |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-04-01
|
| Series: | FEBS Open Bio |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/2211-5463.13957 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
[Comment] Cetuximab plus FOLFOXIRI versus cetuximab plus FOLFOX as conversion regimen in RAS/BRAF wild-type patients with initially unresectable colorectal liver metastases (TRICE trial): a randomized controlled trial
by: Zhang Rongxin
Published: (2024-08-01) -
A compilation of 13 patients with metastatic colorectal cancer and concomitant BRAF and RAS family mutations
by: Jigisha Srivastav, et al.
Published: (2025-08-01) -
Impact of RAS, BRAF mutations and microsatellite status in peritoneal metastases from colorectal cancer treated with cytoreduction + HIPEC: scoping review
by: Valentina Zucchini, et al.
Published: (2025-12-01) -
BRAF-mutant melanoma management: a single center retrospective analysis of patients treated with sequential therapy
by: Ilaria Proietti, et al.
Published: (2024-12-01) -
Surrogate to predict overall survival in patients with BRAF V600E-mutant colorectal cancer treated with BRAF inhibitor combinations
by: J. Ros, et al.
Published: (2025-09-01)